Abstract
Depression is a common psychiatric comorbidity among patients with epilepsy (PWE), affecting more than a third of PWE. Management of depression may improve quality of life of epileptic patients. Unfortunately, available antidepressants worsen epilepsy by reducing the seizure threshold. This situation demands search of new safer target for combined directorate of epilepsy and comorbid depression. A system biology approach may be useful to find novel pathways/markers for the cure of both epilepsy and associated depression via analyzing available genomic and proteomic information. Hence, the system biology approach using curated 64 seed genes involved in temporal lobe epilepsy and mental depression was applied. The interplay of 600 potential proteins was revealed by the Disease Module Detection (DIAMOnD) Algorithm for the treatment of both epilepsy and comorbid depression using these seed genes. The gene enrichment analysis of seed and diamond genes through DAVID suggested 95 pathways. Selected pathways were refined based on their syn or anti role in epilepsy and depression. In conclusion, total 8 pathways and 27 DIAMOnD genes/proteins were finally deduced as potential new targets for modulation of selected pathways to manage epilepsy and comorbid depression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data is available in the manuscript and supplementary files.
References
Agusti A, Sobradillo P, Celli B (2011) Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med 183(9):1129–1137. https://doi.org/10.1164/rccm.201009-1414PP
AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, Saad HM, Batiha GE (2024) The possible role of brain-derived neurotrophic factor in epilepsy. Neurochem Res 49(3):533–547. https://doi.org/10.1007/s11064-023-04064-x
Barabási AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12(1):56–68. https://doi.org/10.1038/nrg2918
Cardamone L, Salzberg MR, O’Brien TJ, Jones NC (2013) Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol 168(7):1531–1554. https://doi.org/10.1111/bph.12052
Castañeda-Cabral JL, Beas-Zárate C, Rocha-Arrieta LL, Orozco-Suárez SA, Alonso-Vanegas M, Guevara-Guzmán R, Ureña-Guerrero ME (2019) Increased protein expression of VEGF-A, VEGF-B, VEGF-C and their receptors in the temporal neocortex of pharmacoresistant temporal lobe epilepsy patients. J Neuroimmunol 328:68–72. https://doi.org/10.1016/j.jneuroim.2018.12.007
Castillo MFR, Cohen A, Edberg D, Hoppensteadt D, Fareed J, Martin B, Halaris A (2020) Vascular endothelial growth factor in bipolar depression: a potential biomarker for diagnosis and treatment outcome prediction. Psychiatry Res 284:112781. https://doi.org/10.1016/j.psychres.2020.112781
Castrén E, Monteggia LM (2021) Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiat 90(2):128–136. https://doi.org/10.1016/j.biopsych.2021.05.008
Cerri C, Caleo M, Bozzi Y (2017) Chemokines as new inflammatory players in the pathogenesis of epilepsy. Epilepsy Res 136:77–83. https://doi.org/10.1016/j.eplepsyres.2017.07.016
Ceyzériat K, Abjean L, Carrillo-de Sauvage MA, Ben Haim L, Escartin C (2016) The complex STATes of astrocyte reactivity: how are they controlled by the JAK-STAT3 pathway? Neuroscience 330:205–218. https://doi.org/10.1016/j.neuroscience.2016.05.043
Chaudhary R (2021) Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis. Heliyon 7(3):e06502. https://doi.org/10.1016/j.heliyon.2021.e06502
Chen Y, Nagib MM, Yasmen N, Sluter MN, Littlejohn TL, Yu Y, Jiang J (2023) Neuroinflammatory mediators in acquired epilepsy: an update. Inflamm Res 72(4):683–701. https://doi.org/10.1007/s00011-023-01700-8
Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ, Zhang C, Lamb J, Edwards S, Sieberts SK, Leonardson A, Castellini LW, Wang S, Champy MF, Zhang B, Emilsson V, Doss S, Ghazalpour A, Horvath S, Drake TA, Lusis AJ, Schadt EE (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452(7186):429–435
Curzytek K, Leśkiewicz M (2021) Targeting the CCL2-CCR2 axis in depressive disorders. Pharmacol Rep 73(4):1052–1062. https://doi.org/10.1007/s43440-021-00280-w
Dang R, Cai H, Zhang L, Liang D, Lv C, Guo Y, Yang R, Zhu Y, Jiang P (2016) Dysregulation of Neuregulin-1/ErbB signaling in the prefrontal cortex and hippocampus of rats exposed to chronic unpredictable mild stress. Physiol Behav 154:145–150. https://doi.org/10.1016/j.physbeh.2015.11.023
Danzer SC (2012) Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 233(1):22–32. https://doi.org/10.1016/j.expneurol.2011.05.023
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5):P3
Epps SA, Weinshenker D (2013) Rhythm and blues: animal models of epilepsy and depression comorbidity. Biochem Pharmacol 85(2):135–146. https://doi.org/10.1016/j.bcp.2012.08.016
Farooq RK, Asghar K, Kanwal S, Zulqernain A (2017) Role of inflammatory cytokines in depression: focus on interleukin-1β. Biomed Rep 6(1):15–20. https://doi.org/10.3892/br.2016.807
Galic MA, Riazi K, Pittman QJ (2012) Cytokines and brain excitability. Front Neuroendocrinol 33(1):116–125. https://doi.org/10.1016/j.yfrne.2011.12.002
GBD 2016 Epilepsy Collaborators (2019) Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18(4):357–375. https://doi.org/10.1016/S1474-4422(18)30454-X
Ghiassian SD, Menche J, Barabási AL (2015) A disease module detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human interactome. PLoS Comput Biol 11(4):e1004120. https://doi.org/10.1371/journal.pcbi.1004120
Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL (2007) The human disease network. Proc Natl Acad Sci USA 104(21):8685–8690. https://doi.org/10.1073/pnas.0701361104
Gorter JA, Iyer A, White I, Colzi A, van Vliet EA, Sisodiya S, Aronica E (2014) Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy. Neurobiol Dis 62:508–520. https://doi.org/10.1016/j.nbd.2013.10.026
Guerrera CS, Furneri G, Grasso M, Caruso G, Castellano S, Drago F, Di Nuovo S, Caraci F (2020) Antidepressant drugs and physical activity: a possible synergism in the treatment of major depression? Front Psychol 11:857. https://doi.org/10.3389/fpsyg.2020.00857
Han CL, Ge M, Liu YP, Zhao XM, Wang KL, Chen N, Meng WJ, Hu W, Zhang JG, Li L, Meng FG (2018) LncRNA H19 contributes to hippocampal glial cell activation via JAK/STAT signaling in a rat model of temporal lobe epilepsy. J Neuroinflammation 15(1):103. https://doi.org/10.1186/s12974-018-1139-z
Heinisch S, Kirby LG (2009) Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuroscience 164(3):1210–1223. https://doi.org/10.1016/j.neuroscience.2009.08.075
Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O (2006) Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 59(1):35–41. https://doi.org/10.1002/ana.20685
Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van’t Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Waes CV, Chen Z, Collisson EA, Cancer Genome Atlas Research Network, Benz CC, Perou CM, Stuart JM (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158(4):929–944. https://doi.org/10.1016/j.cell.2014.06.049
Hodges SL, Lugo JN (2018) Wnt/β-catenin signaling as a potential target for novel epilepsy therapies. Epilepsy Res 146:9–16. https://doi.org/10.1016/j.eplepsyres.2018.07.002
Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4(11):682–690. https://doi.org/10.1038/nchembio.118
Hosseinzadeh M, Pourbadie HG, Khodagholi F, Daftari M, Naderi N, Motamedi F (2019) Preconditioning with toll-like receptor agonists attenuates seizure activity and neuronal hyperexcitability in the pilocarpine rat model of epilepsy. Neuroscience 408:388–399. https://doi.org/10.1016/j.neuroscience.2019.04.020
Huang C, Fu XH, Zhou D, Li JM (2015) The role of wnt/β-catenin signaling pathway in disrupted hippocampal neurogenesis of temporal lobe epilepsy: a potential therapeutic target? Neurochem Res 40(7):1319–1332. https://doi.org/10.1007/s11064-015-1614-1
Ideker T, Sharan R (2008) Protein networks in disease. Genome Res 18(4):644–652. https://doi.org/10.1101/gr.071852.107
Iughetti L, Lucaccioni L, Fugetto F, Predieri B, Berardi A, Ferrari F (2018) Brain-derived neurotrophic factor and epilepsy: a systematic review. Neuropeptides 72:23–29. https://doi.org/10.1016/j.npep.2018.09.005
Jessberger S, Parent JM (2015) Epilepsy and adult neurogenesis. Cold Spring Harb Perspect Biol 7(12):a020677. https://doi.org/10.1101/cshperspect.a020677
Kanner AM (2016) Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol 12(2):106–116. https://doi.org/10.1038/nrneurol.2015.243
Kanner AM, Schachter SC, Barry JJ, Hesdorffer DC, Mula M, Trimble M, Hermann B, Ettinger AE, Dunn D, Caplan R, Ryvlin P, Gilliam F, LaFrance WC Jr (2012) Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 24(2):156–168. https://doi.org/10.1016/j.yebeh.2012.01.007
Klein S, Bankstahl JP, Löscher W, Bankstahl M (2015) Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy. Exp Neurol 263:263–271. https://doi.org/10.1016/j.expneurol.2014.09.004
Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2(7):a006502. https://doi.org/10.1101/cshperspect.a006502
Lagunin AA, Ivanov SM, Gloriozova TA, Pogodin PV, Filimonov DA, Kumar S, Goel RK (2020) Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia. Sci Rep 10(1):257. https://doi.org/10.1038/s41598-019-57199-9
Lee BH, Kim YK (2012) Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disord 136(1–2):181–184. https://doi.org/10.1016/j.jad.2011.07.021
Li KX, Lu YM, Xu ZH, Zhang J, Zhu JM, Zhang JM, Cao SX, Chen XJ, Chen Z, Luo JH, Duan S, Li XM (2011) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat Neurosci 15(2):267–273. https://doi.org/10.1038/nn.3006
Liu J, Zhu HX, Fu WL, Xu XW, Yang JZ, Dai D, Li Y (2019) Downregulated hippocampal expression of brain derived neurotrophic factor and tyrosine kinase B in a rat model of comorbid epilepsy and depression. Neurol Res 41(5):437–445. https://doi.org/10.1080/01616412.2019.1576358
Maguire MJ, Weston J, Singh J, Marson AG (2014) Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev 2014(12):CD010682. https://doi.org/10.1002/14651858.CD010682.pub2
Milenkovic VM, Stanton EH, Nothdurfter C, Rupprecht R, Wetzel CH (2019) The role of chemokines in the pathophysiology of major depressive disorder. Int J Mol Sci 20(9):2283. https://doi.org/10.3390/ijms20092283
Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, Ho RC (2018) IL-1β, IL-6, TNF- α and CRP in elderly patients with depression or alzheimer’s disease: systematic review and meta-analysis. Sci Rep 8(1):12050. https://doi.org/10.1038/s41598-018-30487-6
Nikitidou L, Kanter-Schlifke I, Dhondt J, Carmeliet P, Lambrechts D, Kokaia M (2012) VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures. PLoS ONE 7(7):e40535. https://doi.org/10.1371/journal.pone.0040535
Okamoto OK, Janjoppi L, Bonone FM, Pansani AP, da Silva AV, Scorza FA, Cavalheiro EA (2010) Whole transcriptome analysis of the hippocampus: toward a molecular portrait of epileptogenesis. BMC Genomics 11:230. https://doi.org/10.1186/1471-2164-11-230
Oti M, Snel B, Huynen MA, Brunner HG (2006) Predicting disease genes using protein-protein interactions. J Med Genet 43(8):691–698. https://doi.org/10.1136/jmg.2006.041376
Pineda E, Shin D, Sankar R, Mazarati AM (2010) Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms. Epilepsia 51(3):110–114. https://doi.org/10.1111/j.1528-1167.2010.02623.x
Pineda JR, Encinas JM (2016) The contradictory effects of neuronal hyperexcitation on adult hippocampal neurogenesis. Front Neurosci 10:74. https://doi.org/10.3389/fnins.2016.00074
Piñero J, Ramírez-Anguita JM, Saüch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI (2020) The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 48(D1):D845–D855. https://doi.org/10.1093/nar/gkz1021
Rana A, Musto AE (2018) The role of inflammation in the development of epilepsy. J Neuroinflammation 15(1):144. https://doi.org/10.1186/s12974-018-1192-7
Ren J, Xiao H (2023) Exercise for mental well-being: exploring neurobiological advances and intervention effects in depression. Life (basel, Switzerland) 13(7):1505. https://doi.org/10.3390/life13071505
Roskoski R Jr (2022) Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders. Pharmacol Res 183:106362. https://doi.org/10.1016/j.phrs.2022.106362
Sano F, Shigetomi E, Shinozaki Y, Tsuzukiyama H, Saito K, Mikoshiba K, Horiuchi H, Cheung DL, Nabekura J, Sugita K, Aihara M, Koizumi S (2021) Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus. JCI Insight 6(9):e135391. https://doi.org/10.1172/jci.insight.135391
Sanz P, Garcia-Gimeno MA (2020) Reactive Glia inflammatory signaling pathways and epilepsy. Int J Mol Sci 21(11):4096. https://doi.org/10.3390/ijms21114096
Shariq AS, Brietzke E, Rosenblat JD, Pan Z, Rong C, Ragguett RM, Park C, McIntyre RS (2018) Therapeutic potential of JAK/STAT pathway modulation in mood disorders. Rev Neurosci 30(1):1–7. https://doi.org/10.1515/revneuro-2018-0027
Sharma A, Menche J, Huang CC, Ort T, Zhou X, Kitsak M, Sahni N, Thibault D, Voung L, Guo F, Ghiassian SD, Gulbahce N, Baribaud F, Tocker J, Dobrin R, Barnathan E, Liu H, Panettieri RA Jr, Tantisira KG, Qiu W, Raby BA, Silverman EK, Vidal M, Weiss ST, Barabási AL (2015) A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. Hum Mol Genet 24(11):3005–3020. https://doi.org/10.1093/hmg/ddv001
Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, Nierenberg AA, Fava M, Wong KK (2008) A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 18(3):230–233. https://doi.org/10.1016/j.euroneuro.2007.06.004
Singh T, Goel RK (2016) Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression. Epilepsy Behav 61:248–257. https://doi.org/10.1016/j.yebeh.2016.05.005
Soltani Khaboushan A, Yazdanpanah N, Rezaei N (2022) Neuroinflammation and proinflammatory cytokines in epileptogenesis. Mol Neurobiol 59(3):1724–1743. https://doi.org/10.1007/s12035-022-02725-6
Stefanović BV, Virijević KM, Spasojević NM, Ferizović HN, Janković MD, Vasljević PJ, Dronjak SS (2023) Dysregulation of NF-kB and JAK2/STAT3 signaling in the hippocampus of female WKY strain, a genetic animal model of depression. Kragujevac Journal of Science 45:149–158
Sun H, Ma D, Cheng Y, Li J, Zhang W, Jiang T, Li Z, Li X, Meng H (2023) The JAK-STAT signaling pathway in epilepsy. Curr Neuropharmacol 21(10):2049–2069. https://doi.org/10.2174/1570159X21666221214170234
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607–D613. https://doi.org/10.1093/nar/gky1131
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45(D1):D362–D368. https://doi.org/10.1093/nar/gkw937
Tan GH, Liu YY, Hu XL, Yin DM, Mei L, Xiong ZQ (2011) Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. Nat Neurosci 15(2):258–266. https://doi.org/10.1038/nn.3005
Tian DS, Peng J, Murugan M, Feng LJ, Liu JL, Eyo UB, Zhou LJ, Mogilevsky R, Wang W, Wu LJ (2017) Chemokine CCL2-CCR2 signaling induces neuronal cell death via STAT3 activation and IL-1β production after status epilepticus. J Neurosci 37(33):7878–7892. https://doi.org/10.1523/JNEUROSCI.0315-17.2017
Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23(25):8692–8700. https://doi.org/10.1523/JNEUROSCI.23-25-08692.2003
Wu Y, Wang X, Mo X, Xi Z, Xiao F, Li J, Zhu X, Luan G, Wang Y, Li Y, Zhang J (2008) Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. Clin Neuropathol 27(2):55–63. https://doi.org/10.5414/npp27055
Xu J, Li Y (2006) Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics 22(22):2800–2805. https://doi.org/10.1093/bioinformatics/btl467
Yadav BS, Tripathi V (2018) Recent advances in the system biology-based target identification and drug discovery. Curr Top Med Chem 18(20):1737–1744. https://doi.org/10.2174/1568026618666181025112344
Zhang K, Lin W, Zhang J, Zhao Y, Wang X, Zhao M (2020) Effect of Toll-like receptor 4 on depressive-like behaviors induced by chronic social defeat stress. Brain and Behavior 10(3):e01525. https://doi.org/10.1002/brb3.1525
Zhang S, Chen F, Zhai F, Liang S (2022) Role of HMGB1/TLR4 and IL-1β/IL-1R1 signaling pathways in epilepsy. Front Neurol 13:904225. https://doi.org/10.3389/fneur.2022.904225
Author information
Authors and Affiliations
Contributions
Arvinder Kaur: Data curation, Investigation, Methodology, Writing manuscript. Raji: Data curation, Formal analysis, Validation. Varinder Verma: Writing manuscript, InvestigationRajesh Kumar Goel: Conceptualisation, Writing – review & editing, Project administration, Resources, Supervision.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kaur, A., Raji, Verma, V. et al. Strategic pathway analysis for dual management of epilepsy and comorbid depression: a systems biology perspective. In Silico Pharmacol. 12, 36 (2024). https://doi.org/10.1007/s40203-024-00208-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40203-024-00208-1